Doximity, Inc. (NASDAQ:DOCS – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-two brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $66.1053.
A number of equities analysts have issued reports on DOCS shares. Bank of America raised Doximity from a “neutral” rating to a “buy” rating and upped their target price for the company from $75.00 to $82.00 in a research report on Monday, October 27th. JPMorgan Chase & Co. restated an “underweight” rating and issued a $62.00 price target on shares of Doximity in a research note on Friday, October 10th. KeyCorp reduced their price objective on shares of Doximity from $75.00 to $60.00 and set an “overweight” rating on the stock in a research note on Thursday. Canaccord Genuity Group set a $48.00 price objective on shares of Doximity in a report on Thursday. Finally, Royal Bank Of Canada initiated coverage on shares of Doximity in a research report on Thursday. They issued an “outperform” rating and a $59.00 target price for the company.
Check Out Our Latest Analysis on DOCS
Insiders Place Their Bets
Institutional Investors Weigh In On Doximity
Institutional investors have recently made changes to their positions in the company. Central Pacific Bank Trust Division lifted its stake in Doximity by 41.9% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,752 shares of the company’s stock worth $210,000 after purchasing an additional 1,402 shares during the last quarter. Allworth Financial LP raised its holdings in shares of Doximity by 369.7% during the third quarter. Allworth Financial LP now owns 40,952 shares of the company’s stock worth $2,996,000 after purchasing an additional 32,233 shares during the period. Swiss Life Asset Management Ltd lifted its position in shares of Doximity by 1.2% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 209,829 shares of the company’s stock worth $15,349,000 after buying an additional 2,489 shares during the last quarter. Tevis Investment Management lifted its position in shares of Doximity by 7.9% in the 3rd quarter. Tevis Investment Management now owns 7,229 shares of the company’s stock worth $529,000 after buying an additional 528 shares during the last quarter. Finally, CIBC Bancorp USA Inc. acquired a new position in shares of Doximity in the 3rd quarter valued at about $908,000. 87.19% of the stock is currently owned by institutional investors.
Doximity Price Performance
Shares of DOCS stock opened at $43.81 on Tuesday. The company’s fifty day moving average price is $48.46 and its two-hundred day moving average price is $59.77. The firm has a market capitalization of $8.25 billion, a P/E ratio of 43.81, a P/E/G ratio of 4.10 and a beta of 1.39. Doximity has a 12 month low of $43.21 and a 12 month high of $85.21.
Doximity (NASDAQ:DOCS – Get Free Report) last announced its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The business’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.30 EPS. On average, sell-side analysts anticipate that Doximity will post 0.99 EPS for the current year.
About Doximity
Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”
The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.
Recommended Stories
- Five stocks we like better than Doximity
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.
